Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate CancerJames A Eastham, Glenn Heller, Susan Halabi, et al.
Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillanceHyung L Kim, Ping Li, Huei-Chung Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Prostate cancer, version 1.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelinesJames L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Prostate cancer, version 2.2014James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJames L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, et al.
International Journal of Cancer|September 15, 2020
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Human Genetics|February 27, 2015
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 casesBrian T Helfand, Kimberly A Roehl, Phillip R Cooper, et al.
Pageof 37